Brief: Cleveland BioLabs reports Q3 net loss per share, excluding minority interests, $0.11

Statera Biopharma

14/11/2017 13:20

Nov 14 (Reuters) - Cleveland BioLabs Inc  CBLI.O  
    * Cleveland BioLabs reports third quarter 2017 financial 
results 
and development progress 
    * Q3 revenue $300,000 versus $1.1 million 
    * Cleveland BioLabs Inc - qtrly net loss, excluding 
minority 
interests, $0.11 per share 
    * Cleveland BioLabs -current cash,cash 
equivalents,short-term 
investments is expected to fund operations for at least 1 year 
beyond filing date of form 10-Q 
 
Source text for Eikon:  ID:nMKWP5VsMa  
Further company coverage:  CBLI.O  
 
 ((bangalore.newsroom@thomsonreuters.com;))